Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00067587 · ClinicalTrials.gov registry record

Metabolic Abnormalities in HIV Infected and Uninfected Young Women

A clinical trial of HIV Infections and Hypercholesterolemia, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
300
Enrollment target
11
Study locations

NCT00067587 is a study of HIV Infections and Hypercholesterolemia that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 300 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (33% lower). The trial reports 11 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00067587, a study of HIV Infections and Hypercholesterolemia, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
300 participants
Enrollment target
11
Study locations

Study Summary

Though anti-HIV drugs can dramatically improve the health of people with HIV, some people taking these drugs develop serious long term effects in their metabolism. These effects include problems with bones, increased levels of blood sugar and lipids, and changes in body fat distribution. The purpose of this study is to see how many young women are experiencing these problems and how severe the problems are. This kind of study is the first step in determining how best to treat these problems.

Conditions Studied

HIV Infections Hypercholesterolemia Glucose Intolerance

Study Locations (11)

Florida

  • Children's Diagnostic and Treatment Center - Fort Lauderdale
  • University of Miami - Miami
  • University of South Florida - Tampa

California

  • Children's Hopsital of Los Angeles - Los Angeles
  • University of California at San Diego - San Diego

New York

  • Mt. Sinai Hospital - New York
  • Montefiore Medical Center - The Bronx

District of Columbia

  • Children's National Medical Center - Washington D.C.

Illinois

  • Stoger Hospital of Cook County - Chicago

Louisiana

  • Tulane University - New Orleans

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2003-07
Est. Completion 2005-06

Sponsor

University of North Carolina, Chapel Hill

1,109 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00067587

The ClinicalTrials.gov registry entry for NCT00067587 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (33% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00067587 reports 11 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, New York.

Frequently Asked Questions

What is clinical trial NCT00067587 about?

NCT00067587 is a clinical study titled "Metabolic Abnormalities in HIV Infected and Uninfected Young Women". Though anti-HIV drugs can dramatically improve the health of people with HIV, some people taking these drugs develop serious long term effects in their metabolism. These effects include problems with bones, increased levels of blood sugar and lipids, and changes in body fat distribution. The purpose...

What is the current status of trial NCT00067587?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2003-07. Estimated completion is 2005-06.

What conditions does trial NCT00067587 study?

This clinical trial studies the following conditions: HIV Infections, Hypercholesterolemia, Glucose Intolerance.

Who is sponsoring clinical trial NCT00067587?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00067587 being conducted?

This trial has 11 study locations across California, District of Columbia, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Hypercholesterolemia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.